0001387131-15-002579.txt : 20150817
0001387131-15-002579.hdr.sgml : 20150817
20150817172954
ACCESSION NUMBER: 0001387131-15-002579
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150813
FILED AS OF DATE: 20150817
DATE AS OF CHANGE: 20150817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp
CENTRAL INDEX KEY: 0000887247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820429727
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 310
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 997-2400
MAIL ADDRESS:
STREET 1: 11455 EL CAMINO REAL
STREET 2: SUITE 310
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHERMEL ROBERT B
CENTRAL INDEX KEY: 0001277431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36242
FILM NUMBER: 151059686
MAIL ADDRESS:
STREET 1: 828 BALMORAL LN
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
4
1
rothermel-form4_081315.xml
OWNERSHIP DOCUMENT
X0306
4
2015-08-13
0
0000887247
Adamis Pharmaceuticals Corp
ADMP
0001277431
ROTHERMEL ROBERT B
C/O ADAMIS PHARMACEUTICALS CORPORATION
11682 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
0
0
0
Common Stock
2015-08-13
2015-08-13
4
P
0
5000
3.2988
A
25000
D
Common Stock
2015-08-14
2015-08-14
4
P
0
2000
3.3998
A
27000
D
The price reported in Column 4 is a weighted avergae price. These shares were purchased in multiple transactions at prices ranging from $3.24 to $3.30, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.358 to $3.426, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.
/s/ Robert O. Hopkins, Power of Attorney For Robert B. Rothermel
2015-08-17